Turkey: Promotion And Advertising Of Medical Devices In Turkey: How Many Shades Of Grey?

Last Updated: 13 February 2013
Article by Ozge Atilgan Karakulak and Ceren Aral

There have been specific rules governing the promotion of medicinal products in Turkey since the beginning of the 90's. The Regulation on Promotion of Medicinal Products for Human Use ("The Medicinal Products Promotion Regulation") of the Ministry of Health ("MoH") provides specific rules on promotion of medicinal products through interactions with health care professionals (HCPs) in areas such as sharing of information and material by product representatives, product samples, congress sponsorship, whilst advertising to public is strictly prohibited. The Medicinal Products Promotion Regulation also deals with donations, although donations cannot be used as a promotion tool.

The Medicinal Products Promotion Regulation does not cover medical devices ("MD or MDs") and there are no specific rules for MDs from the perspectives of neither interactions with HCPs nor advertising to the public. The promotion of medical devices through interaction with HCPs is governed by the law applicable to civil servants, predominantly ethics rules preventing the civil servant HCPs to demand or receive benefits for the exercising of the public service. On the other hand, advertising to public is governed by general rules, i.e. under consumer protection, advertising and unfair competition law.

Despite the lack of applicable provisions specific to medical devices, it was observed that in practice when it came to interaction with HCPs, the MoH did not in principle differentiate medical devices from medicinal products. The MoH expected the medical device manufacturers/distributors to comply with almost the same standards applied to medicinal products.

In 2011 the MoH wanted to clarify the grey areas and provide a regulatory framework for the promotion of MDs. The MoH was already engaged in the process of revising The Medicinal Products Promotion Regulation and most probably considered that it would be practical to also include MDs within the scope of the revised version. Accordingly, the MoH opened The Draft Regulation on Promotion of Medicinal Products for Human Use and Medical Devices and Health Declarations Provided for Promotions of Products for comments and suggestions from the industry.

The inclusion of MDs within this draft regulation was not welcomed by the industry. It almost seemed like the term MD had been included within the draft which was originally designed only to be for medicinal products. Therefore the regulation in the overall did not make much sense for MDs.

Medicinal products and MDs differed substantially on some important points like channels of trade, users, market entry conditions, classification, license/approval requirements. Therefore the application of the exact same product rules for medical devices was too strict for the nature of some types of MDs and thus not practical.

For example, just as in the case of medicinal products, the draft regulation prevented advertising of medical devices altogether irrespective of the medical device being subjected to the professional use of HCPs or everyday use of patients or consumers.

Moreover, the draft regulation provided significant quotas on sample products for MDs. Sample products are of significant importance for medicinal products, but medical devices are mostly promoted through demo products. There was uncertainty as to whether demo products could still be provided and if so, whether the same quotas would be applicable to them too.

To sum up, this drastic change from no specific provisions to having provisions applicable to medicinal products did not gain much support from both public and private entities within the health care sector. Eventually, it was unofficially confirmed by the MoH that specific provisions would be introduced for promotion and advertising of medical devices. Such provisions would not be formulated within the same document as medicinal products but as a seperate regulation covering medical devices only, taking into account their nature and specifics.

The MoH then moved on to publish the amended "Medicinal Product Promotion Regulation" on August 26, 2011 without any reference to medical devices within its scope1. The MoH subsequently opened the Draft Regulation on Advertising and Promotion of Medical Devices ("The New Draft Regulation") to comments and suggestions from the industry. The New Draft Regulation allowed advertising of non-professional medical devices to the public pursuant to both general advertising rules and some specific provisions arising from the nature of medical devices. It further set almost the same standards for the promotion of medical devices to HCPs, where under a few specific provisions the medical devices were subjected to lighter requirements compared to medicinal products. The New Draft Regulation was expected to be published before the beginning of 2012 and enter into force one year from its publication. However, as of today the MoH has not published this legislation yet.

At the current stage the real problem arises from the fact that the interactions with HCPs for pharmaceutical companies are strictly regulated, whereas there is still no regulation for medical devices. Even though at the first glance this may seem liberating for the medical device companies, the industry often finds itself faced with obstacles as there exists many grey areas of practice which can result in the risk of the MoH holding medical device companies responsible by relying on general provisions.

For example, relating to sponsorships, The Medicinal Products Promotion Regulation sets forth a rule commonly referred to as 3-2-1 rule. Under this rule an HCP can receive maximum three congress sponsorships from pharmaceutical companies. A maximum of two of these sponsorships may come from the same pharmaceutical company and a maximum of one of them can be an international congress. Furthermore, as the mere reflection of the global transparency rules in Turkey, the pharmaceutical companies are obliged to submit all the details in relation to the congress sponsorship to MoH's online database and obtain approval before the attendance takes place. Under the current regulatory framework, the medical device companies are not legally bound to make such online notification and obtain an approval. However in case they sponsor the HCP above the HCP's quota, the HCP and the MD company may be held responsible by the MoH. It gets significantly important where the same entity operates both in the areas of medicinal products and MDs.

On the other hand, regarding advertising to public, though it is not an official statement, it is known that in 2012 the MoH shared its view with the industry during its sector meetings that when the Draft Medical Device Promotion Regulation is published, the advertising of MDs will be prohibited altogether. This point of view was later confirmed by official letters sent by the industry associations. This was not supported, as prohibiting advertisement of all MDs including the ones that require no HCP intervention for selection and application would not protect the patients or consumers but would result in detriment caused to their access to information. In this respect, it is known that a Turkish medical association presented a suggestion to the MoH where the advertising of the MDs will be evaluated based on whether the device is for the use of health care professionals or patients. In this respect, for the professional devices that are prescribed and/or exclusively applied by the HCPs, the advertising to public would be forbidden and only promotion to HCPs would be permitted. For the non-professional devices that do not require any kind of intervention of an HCP and/or a prescription, the advertising would be possible without any specific limitations.

As of today, the issue remains unclear. However it can be said that the MD industry wishes to actually have the promotion and advertising of MDs regulated in order to overcome these many shades of grey. It is expected that the issue will get some clarity in 2013 with solutions that are hoped to be in a practical and reasonable manner.


1.This regulation was again amended on October 14, 2012.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Ozge Atilgan Karakulak
Ceren Aral
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.